Methods and Compositions for Treating Genetically Linked Diseases of the Eye The National Eye Institute (NEI) seeks a co-development partner to co-lead a pivotal multicenter trial and commercialize its AAV-RS1 Gene Therapy for X-linked retinoschisis (XLRS).Therapeutics
